Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

8 results
Display

The Current Status of Development of Korean Clinical Practice Guidelines in Urology

Yeo JK, Park MG

The clinical practice guidelines (CPGs) is made step by step. The evidences that have been published were searched and a group of experts make a consensus based in the evidences....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Treatment of Metastatic and Castration-Resistant Prostate Cancer Patients in Korea

Hah YS, Ha US, Jung JW, Park BH, Kim HJ, Kim KH, Yeo JK

The treatment of advanced prostate cancer has rapidly evolved. Androgen deprivation therapy is recognized as the first-line therapy for metastatic disease; however, a substantial proportion of patients will eventually progress...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of Patients With High Risk Prostate Cancer

Kim JW, Kim KT, Park JY, Yeo J

The Korean Urological Oncology Society has developed a guideline for treatment of prostate cancer by adapting various prostate cancer guidelines in a systematic manner in order to create a guideline...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Treatments for Low-Risk Prostate Cancer

Lee JW, Jeong JY, Cho IC, Kim SH, Kwon WA, Choi M, Yeo JK

Recently, the prevalence of prostate cancer has been increased with the screening of prostate-specific antigen and the increase in the elderly population. In particular, the diagnosis of the low-risk prostate...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Primary Leiomyosarcoma in Bladder

Kang TW, Eom MS, Chung HC

Leiomyosarcoma of the bladder is a very rare tumor and it has been reported in less than 200 cases in the literature which represent 0.1% of all nonurothelial bladder tumors....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Unilateral Multifocal Type 2 Papillary Renal Cell Carcinoma in Adolescence. A Case Report

Yoon S, Choi JH, Lee SW, Jeh SU, Hwa JS, Hyun JS, Chung KH, Park HO, Lee JS, Choi SM

Papillary renal cell carcinomas (RCCs) can be classified into 2 subtypes (types 1 and 2), depending on their characteristic cytogenetics, immunostaining profiles, and gene-expression profiles. Compared with type 1 papillary...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Treatments for Intermediate Risk Prostate Cancer

Shim M, Kwon T, Kim SC, Kim WS, Choo MS, Yeo JK

The population of intermediate-risk prostate cancer patients is a large heterogeneous group with diverse prognoses and challenges the struggle to develop more meticulous and standardized treatment recommendations. Furthermore, there are...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Serial Comparison of Cancer Detection Rate Between Transrectal Ultrasound Sonography Guided Biopsy and Magnetic Resonance Imaging for Repeat Biopsy by a Propensity Score Matching Cohort: A Single Center Experience

Bang S, Choi YH, Kang M, Jeon HG, Jeong BC, Seo SI, Jeon SS, Kim CK, Park BK, Lee HM

PURPOSE: To compare biopsy performance of 2 approaches for multiparametric magnetic resonance imaging (MRI) guided biopsy and transrectal ultrasonography (TRUS)-guided biopsy with 2nd and 3rd repeat biopsy patients in prostate...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr